NEW YORK (GenomeWeb News) - Alnylam Pharmaceuticals has promoted Barry Greene from COO to president and COO, the firm announced today. He will continue to report to CEO John Maraganore. Prior to Alnylam, Greene was general manager of oncology at Millennium Pharmaceuticals.
 

 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

The UK's Human Fertility and Embryology Authority calls for consumer genetic testing companies to warn customers that testing could uncover family secrets, according to the Guardian.

The New York Times reports that United Nations delegates have been discussing how to govern the genetic resources of the deep sea.

Researchers have transplanted edited cells into mice that appear to combat cocaine addiction, New Scientist reports.

In PNAS this week: analysis of proteolytic enzymes secreted by circulating tumor cells, phylogenetic study of Fv1 evolution, and more.